Shopping Cart
- Remove All
- Your shopping cart is currently empty
Rafivirumab (CR57) is a monoclonal antibody targeting the rabies virus G protein, used in the study of rabies virus infection.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $228 | In Stock | |
5 mg | $589 | In Stock | |
10 mg | $959 | In Stock | |
25 mg | $1,420 | In Stock | |
50 mg | $1,920 | In Stock |
Description | Rafivirumab (CR57) is a monoclonal antibody targeting the rabies virus G protein, used in the study of rabies virus infection. |
In vitro | Rafivirumab completely neutralizes the wild type ERA439 and N336D R346K with an EC50 of 3-5 pg/mL. [1] |
In vivo | Rafivirumab improves survival in rats infected with rabies virus by intrathecal inoculation. [2] Rafivirumab (3-12 μg/kg, intramuscular injection) improved survival in Syrian hamsters infected with bat rabies virus [1]. |
Alias | CR57, CR 57 |
Cas No. | 944548-37-2 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.